Mai, Z., Liu, Q., Li, Q., Zhu, Y., Zhao, L., Liu, S., Chen, B., Liu, M., Hu, Y., Lin, T., Chen, J., Lv, Y., Fu, J., Xi, M., Yang, H. (2026). Three-year outcomes and multi-omics biomarker discovery of locally advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy and anti-PD-1 antibody from the phase II trial NEOCRTEC1901.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.371